Medistim ASA (LON:0OCD)

Medistim ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	142.42	103.83	103.82	113.97	90.9	69.39
Depreciation & Amortization	22.7	24.51	23.66	23.29	23.43	16.25
Other Amortization	1.65	-	-	-	-	6.89
Other Operating Activities	9.75	2.01	5.69	12.91	9.83	3.17
Change in Accounts Receivable	5.32	5.32	27.35	-33.02	-11.15	4.7
Change in Inventory	-15.13	-15.13	-31.06	-16.92	15.25	-22.6
Change in Accounts Payable	1.95	1.95	0.61	11.27	-0.32	-1.3
Change in Other Net Operating Assets	22.35	20.61	-10.88	2	-0.57	-2.38
Operating Cash Flow	191.02	143.1	119.2	113.49	127.37	74.13
Operating Cash Flow Growth	55.62%	20.06%	5.03%	-10.90%	71.82%	-7.77%
Capital Expenditures	-6.07	-6.07	-16.4	-9.25	-7.4	-7.45
Sale (Purchase) of Intangibles	-18.63	-18.63	-13.33	-11.85	-4.08	-3.19
Investing Cash Flow	-27.68	-24.69	-29.73	-21.1	-11.49	-10.64
Long-Term Debt Repaid	-	-9.12	-8.71	-7.31	-12	-9.68
Net Debt Issued (Repaid)	-9.42	-9.12	-8.71	-7.31	-12	-9.68
Common Dividends Paid	-109.47	-82.41	-82.18	-68.4	-54.64	-50.05
Other Financing Activities	-	-	-	5.4	7.59	1.39
Financing Cash Flow	-131.46	-91.53	-90.89	-70.3	-59.05	-58.35
Foreign Exchange Rate Adjustments	-1.54	-1.54	2.65	1.07	0.76	-
Net Cash Flow	30.34	25.34	1.23	23.15	57.6	5.15
Free Cash Flow	184.95	137.04	102.8	104.24	119.97	66.68
Free Cash Flow Growth	73.91%	33.30%	-1.38%	-13.11%	79.91%	-0.02%
Free Cash Flow Margin	27.93%	24.64%	19.73%	21.44%	28.71%	18.72%
Free Cash Flow Per Share	10.12	7.48	5.62	5.70	6.57	3.66
Cash Income Tax Paid	30.87	28.4	25.7	19.17	13.34	19.05
Levered Free Cash Flow	139.77	81.67	64.81	56.39	98.98	47.3
Unlevered Free Cash Flow	139.77	81.67	64.81	56.47	99.09	47.4
Change in Working Capital	14.5	12.75	-13.97	-36.68	3.21	-21.57

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.